Both in Pharmaceuticals
Capricor Therapeutics vs Faeth Therapeutics
Over the past year CAPR returned +6.6% and FTH returned −46.6%; their daily moves had a correlation of 0.54.
CAPR +6.6% FTH −46.6%Growth of $1, one year, split-adjusted
| Metric | CAPR | FTH |
|---|---|---|
| Price | $8.92 | $19.99 |
| Market cap | $518.6M | $516.6M |
| Today | +8.25% | +1.73% |
| 1 month | +15.1% | −25.7% |
| 6 months | −74.1% | — |
| Year to date | −69.1% | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $237.9M | $174.8M |
| Dividend yield | — | — |
| Volatility (60d) | 144.1% | — |
| Short % of float | 48.4% | 20.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).